|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 18002 |
FusionGeneSummary for JAG1_SLX4IP |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: JAG1_SLX4IP | Fusion gene ID: 18002 | Hgene | Tgene | Gene symbol | JAG1 | SLX4IP | Gene ID | 182 | 128710 |
| Gene name | jagged 1 | SLX4 interacting protein | |
| Synonyms | AGS|AGS1|AHD|AWS|CD339|HJ1|JAGL1 | C20orf94|bA204H22.1|bA254M13.1|dJ1099D15.3 | |
| Cytomap | 20p12.2 | 20p12.2 | |
| Type of gene | protein-coding | protein-coding | |
| Description | protein jagged-1 | protein SLX4IP | |
| Modification date | 20180522 | 20180519 | |
| UniProtAcc | P78504 | Q5VYV7 | |
| Ensembl transtripts involved in fusion gene | ENST00000254958, ENST00000423891, ENST00000488480, | ENST00000334534, | |
| Fusion gene scores | * DoF score | 3 X 3 X 2=18 | 2 X 2 X 2=8 |
| # samples | 3 | 2 | |
| ** MAII score | log2(3/18*10)=0.736965594166206 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(2/8*10)=1.32192809488736 | |
| Context | PubMed: JAG1 [Title/Abstract] AND SLX4IP [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | JAG1 | GO:0001953 | negative regulation of cell-matrix adhesion | 11549580 |
| Hgene | JAG1 | GO:0022408 | negative regulation of cell-cell adhesion | 11549580 |
| Hgene | JAG1 | GO:0030336 | negative regulation of cell migration | 11549580 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| TCGA | LD | CESC | TCGA-MY-A5BE-01A | JAG1 | chr20 | 10622108 | - | SLX4IP | chr20 | 10582379 | + |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| Frame-shift | ENST00000254958 | ENST00000334534 | JAG1 | chr20 | 10622108 | - | SLX4IP | chr20 | 10582379 | + |
| In-frame | ENST00000423891 | ENST00000334534 | JAG1 | chr20 | 10622108 | - | SLX4IP | chr20 | 10582379 | + |
| intron-3CDS | ENST00000488480 | ENST00000334534 | JAG1 | chr20 | 10622108 | - | SLX4IP | chr20 | 10582379 | + |
Top |
FusionProtFeatures for JAG1_SLX4IP |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| JAG1 | SLX4IP |
| Ligand for multiple Notch receptors and involved in themediation of Notch signaling. May be involved in cell-fatedecisions during hematopoiesis. Seems to be involved in early andlate stages of mammalian cardiovascular development. Inhibitsmyoblast differentiation (By similarity). Enhances fibroblastgrowth factor-induced angiogenesis (in vitro). {ECO:0000250,ECO:0000269|PubMed:18660822, ECO:0000269|PubMed:9462510}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for JAG1_SLX4IP |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for JAG1_SLX4IP |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| JAG1 | NOTCH2, NOTCH1, NOTCH3, MLLT4, MIB1, HGS, NEURL1, FBXW7, APBB1 | SLX4IP | SLX4, PAGR1, RNF20, FBXW4, ERCC4, STK4, SYNE2, COPS7A, CUL1, RPN1, RNH1, SLX1B, PLK1, SUMO2, ERCC1, PDCD2L, DLD, MAPK14, IFI30, GORASP1 |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for JAG1_SLX4IP |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for JAG1_SLX4IP |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | JAG1 | C1956125 | Alagille Syndrome 1 | 13 | ORPHANET;UNIPROT |
| Hgene | JAG1 | C0015393 | Eye Abnormalities | 3 | CTD_human |
| Hgene | JAG1 | C0085280 | Alagille Syndrome | 3 | CTD_human |
| Hgene | JAG1 | C0039685 | Tetralogy of Fallot | 2 | CTD_human;HPO;ORPHANET;UNIPROT |
| Hgene | JAG1 | C0282631 | Facies | 2 | CTD_human |
| Hgene | JAG1 | C0005940 | Bone Diseases | 1 | CTD_human |
| Hgene | JAG1 | C0010038 | Corneal Opacity | 1 | CTD_human |
| Hgene | JAG1 | C0010606 | Adenoid Cystic Carcinoma | 1 | CTD_human |
| Hgene | JAG1 | C0011053 | Deafness | 1 | CTD_human |
| Hgene | JAG1 | C0017636 | Glioblastoma | 1 | CTD_human |
| Hgene | JAG1 | C0018798 | Congenital Heart Defects | 1 | CTD_human |
| Hgene | JAG1 | C0024121 | Lung Neoplasms | 1 | CTD_human |
| Hgene | JAG1 | C0036095 | Salivary Gland Neoplasms | 1 | CTD_human |
| Hgene | JAG1 | C0036341 | Schizophrenia | 1 | PSYGENET |
| Hgene | JAG1 | C0887833 | Carcinoma, Pancreatic Ductal | 1 | CTD_human |
| Hgene | JAG1 | C1458155 | Mammary Neoplasms | 1 | CTD_human |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|